Analyst Viewpoint
Surge in prevalence of cardiovascular diseases is primarily propelling the heart pumps market size. Increase in geriatric population, rise in adoption of unhealthy lifestyle, and surge in environmental pollution are augmenting the cases of heart diseases.
Growth in heart care awareness across the globe is also fueling the heart pumps industry value.
Collaborative and focused efforts by governments, healthcare institutions, and advocacy groups have led to a growth in understanding of the benefits of heart pumps, thus augmenting the heart pumps industry demand.
Prominent players in the global heart pumps market are developing advanced heart pumps, which are compact and have extended battery life with remote monitoring, to combat the spur in cases of end stage heart failure.
Heart pumps are mechanical medical devices designed to replace or support the functionalities of a failing heart. They are primarily used for patients with ailing hearts who are unable to pump enough blood to meet the body’s needs.
These devices help improve circulation and alleviate the symptoms of heart failure, thus enhancing the patient’s overall quality of life. Heart pumps can be implanted internally or worn externally. They are designed for patients who are ineligible for transplants or as a temporary measure until the heart recovers.
Recent heart pumps market insights indicate a trend toward development of smaller and durable devices with extended battery life with real-time remote monitoring abilities. Additionally, integration of advancements, including utilization of flow pumps to reduce the risk of complication, is gaining traction.
Benefits such as mitigation of symptoms including shortness of breath and fatigue, extended lifespan, and actual treatment option for end-stage heart failure are boosting the dynamics of the heart pumps industry.
Surge in global geriatric population, rise in environmental pollution, growth in adoption of modern sedentary lifestyle, and genetic predispositions are critical factors leading to the heightened prevalence of cardiovascular diseases.
Work stress and unhealthy habits such as drinking and smoking increase the risk of hypertension, diabetes, and high cholesterol levels, which are major catalysts for the development of heart-related conditions.
On the other hand, advancements in healthcare and diagnostic technologies have resulted in an improvement in the diagnosis of cardiovascular illnesses compared to that in the past decade.
According to The CDC Foundation, about one in three adults or nearly 86 million people in the U.S suffer from at least one type of cardiovascular disease.
The British Heart Foundation states that in 2021, an estimated 20.5 million people died due to cardiovascular conditions. As per the World Health Organization (WHO), nearly 40% of global premature deaths via non-commutable diseases are caused by heart attacks and strokes.
Growth in awareness about the importance of heart care can be ascribed to several factors that include concentrated and collaborative efforts by governments, healthcare organizations, and advocacy groups.
Governments of several countries regularly conduct public information campaigns and offer financial incentives and extensive funding for research to promote healthy lifestyle and improve patient care.
These efforts lead to an increase in awareness about the efficiency and benefits of heart pumps on patient’s overall health among both the healthcare providers and the general population.
Studies across the world suggest that individuals with pre-existing heart conditions are more vulnerable to severe illness and mortality from COVID-19.
The pandemic has led to a surge in awareness and consciousness around one’s health, thus leading to an increase in interest in health screenings, diagnosis, prevention, and cure.
According to the recent heart pumps market analysis, North America held the largest industry share in 2022. Presence of a well-developed healthcare sector, rise in awareness about advanced cardiovascular care technologies, and increase in R&D expenses are augmenting heart pumps industry statistics of the region.
The CDC Foundation states that an estimated one in every six U.S. healthcare dollars is spent on cardiovascular health issues. By 2030, the annual cost related to heart-related diseases is likely to amount to nearly US$ 818.0 Bn in the U.S.
According to the latest heart pumps market forecast, the business in Asia Pacific is projected to grow at a steady pace from 2023 to 2031. Increase in cases of heart attacks, strokes, and other cardiovascular diseases is propelling the market dynamics of the region.
As per the All India Institute of Medical Sciences (AIIMS), strokes are the second most common cause of death among the people in the country. A stroke-related death occurs every four minutes in India, with more than 185,000 cases of stroke reported in the country annually.
Prominent manufacturers of heart pumps are investing significantly in development of artificial heart pumps and implantable heart pumps to offer optimal heart care to patients and improve their quality of life.
Research collaborations among vendors in the heart pumps landscape is a common strategy employed by the leading players to expand their product portfolio.
SynCardia Systems, LLC, Berlin Heart GmbH, Jarvik Heart Inc., Calon Cardio-Technology Ltd., Teleflex Incorporated, Abbott Laboratories, and Medtronic plc are the prominent companies operating in the global landscape.
These firms have been profiled in the heart pumps market research report based on parameters such as business strategies, company overview, business segments, product portfolio, and financial overview.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 2.7 Bn |
| Market Forecast Value in 2031 | US$ 12.3 Bn |
| Growth Rate (CAGR) | 18.3% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 2.7 Bn in 2022
It is projected to advance at a CAGR of 18.3% from 2023 to 2031
Increase in incidence of cardiovascular diseases and rise in heart care awareness
The implantable heart pump devices segment accounted for the largest share in 2022
North America was the leading region in 2022
SynCardia Systems, LLC, Berlin Heart GmbH, Jarvik Heart Inc., Calon Cardio-Technology Ltd., Teleflex Incorporated, Abbott Laboratories, and Medtronic plc
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Heart Pumps Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Heart Pumps Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Heart Pumps Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Intra-aortic Balloon Pumps
6.3.2. Ventricular Assist Devices
6.3.2.1. Left Ventricle Assist Devices (LVAD)
6.3.2.2. Right Ventricle Assist Devices (RVAD)
6.3.2.3. Biventricular Assist Devices (BVAD)
6.3.2.4. Others
6.3.3. Total Artificial Heart
6.4. Market Attractiveness, by Product
7. Global Heart Pumps Market Analysis and Forecast, by Flow Regime
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Flow Regime, 2017–2031
7.3.1. Centrifugal Flow Pump (CFP)
7.3.2. Axial Flow Pump (AFP)
7.3.3. Mixed Flow Pump (MFP)
7.4. Market Attractiveness, by Flow Regime
8. Global Heart Pumps Market Analysis and Forecast, By Therapy
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, By Therapy, 2017–2031
8.3.1. Bridge-to-Candidacy (BTC)
8.3.2. Bridge-to-Transplant (BTT)
8.4. Market Attractiveness, By Therapy
9. Global Heart Pumps Market Analysis and Forecast, by Location
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Location, 2017–2031
9.3.1. Implantable Heart Pump Devices
9.3.2. Extracorporeal Heart Pump Devices
9.4. Market Attractiveness, by Location
10. Global Heart Pumps Market Analysis and Forecast, by End-user
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Specialty Clinics
10.3.4. Others
10.4. Market Attractiveness, by End-user
11. Global Heart Pumps Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017–2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region
12. North America Heart Pumps Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Intra-aortic Balloon Pumps
12.2.2. Ventricular Assist Devices
12.2.2.1. Left Ventricle Assist Devices (LVAD)
12.2.2.2. Right Ventricle Assist Devices (RVAD)
12.2.2.3. Biventricular Assist Devices (BVAD)
12.2.2.4. Others
12.2.3. Total Artificial Heart
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Flow Regime, 2017–2031
12.4.1. Centrifugal Flow Pump (CFP)
12.4.2. Axial Flow Pump (AFP)
12.4.3. Mixed Flow Pump (MFP)
12.5. Market Attractiveness, by Flow Regime
12.6. Market Value Forecast, By Therapy, 2017–2031
12.6.1. Bridge-to-Candidacy (BTC)
12.6.2. Bridge-to-Transplant (BTT)
12.7. Market Attractiveness, By Therapy
12.8. Market Value Forecast, by Location, 2017–2031
12.8.1. Implantable Heart Pump Devices
12.8.2. Extracorporeal Heart Pump Devices
12.9. Market Attractiveness, by Location
12.10. Market Value Forecast, by End-user, 2017–2031
12.10.1. Hospitals
12.10.2. Ambulatory Surgical Centers
12.10.3. Specialty Clinics
12.10.4. Others
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2017–2031
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Product
12.13.2. By Flow Regime
12.13.3. By Therapy
12.13.4. By Location
12.13.5. By End-user
12.13.6. By Country
13. Europe Heart Pumps Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Intra-aortic Balloon Pumps
13.2.2. Ventricular Assist Devices
13.2.2.1. Left Ventricle Assist Devices (LVAD)
13.2.2.2. Right Ventricle Assist Devices (RVAD)
13.2.2.3. Biventricular Assist Devices (BVAD)
13.2.2.4. Others
13.2.3. Total Artificial Heart
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Flow Regime, 2017–2031
13.4.1. Centrifugal Flow Pump (CFP)
13.4.2. Axial Flow Pump (AFP)
13.4.3. Mixed Flow Pump (MFP)
13.5. Market Attractiveness, by Flow Regime
13.6. Market Value Forecast, By Therapy, 2017–2031
13.6.1. Bridge-to-Candidacy (BTC)
13.6.2. Bridge-to-Transplant (BTT)
13.7. Market Attractiveness, By Therapy
13.8. Market Value Forecast, by Location, 2017–2031
13.8.1. Implantable Heart Pump Devices
13.8.2. Extracorporeal Heart Pump Devices
13.9. Market Attractiveness, by Location
13.10. Market Value Forecast, by End-user, 2017–2031
13.10.1. Hospitals
13.10.2. Ambulatory Surgical Centers
13.10.3. Specialty Clinics
13.10.4. Others
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2017–2031
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Product
13.13.2. By Flow Regime
13.13.3. By Therapy
13.13.4. By Location
13.13.5. By End-user
13.13.6. By Country/Sub-region
14. Asia Pacific Heart Pumps Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Intra-aortic Balloon Pumps
14.2.2. Ventricular Assist Devices
14.2.2.1. Left Ventricle Assist Devices (LVAD)
14.2.2.2. Right Ventricle Assist Devices (RVAD)
14.2.2.3. Biventricular Assist Devices (BVAD)
14.2.2.4. Others
14.2.3. Total Artificial Heart
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Flow Regime, 2017–2031
14.4.1. Centrifugal Flow Pump (CFP)
14.4.2. Axial Flow Pump (AFP)
14.4.3. Mixed Flow Pump (MFP)
14.5. Market Attractiveness, by Flow Regime
14.6. Market Value Forecast, By Therapy, 2017–2031
14.6.1. Bridge-to-Candidacy (BTC)
14.6.2. Bridge-to-Transplant (BTT)
14.7. Market Attractiveness, By Therapy
14.8. Market Value Forecast, by Location, 2017–2031
14.8.1. Implantable Heart Pump Devices
14.8.2. Extracorporeal Heart Pump Devices
14.9. Market Attractiveness, by Location
14.10. Market Value Forecast, by End-user, 2017–2031
14.10.1. Hospitals
14.10.2. Ambulatory Surgical Centers
14.10.3. Specialty Clinics
14.10.4. Others
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2017–2031
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Product
14.13.2. By Flow Regime
14.13.3. By Therapy
14.13.4. By Location
14.13.5. By End-user
14.13.6. By Country/Sub-region
15. Latin America Heart Pumps Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Intra-aortic Balloon Pumps
15.2.2. Ventricular Assist Devices
15.2.2.1. Left Ventricle Assist Devices (LVAD)
15.2.2.2. Right Ventricle Assist Devices (RVAD)
15.2.2.3. Biventricular Assist Devices (BVAD)
15.2.2.4. Others
15.2.3. Total Artificial Heart
15.3. Market Attractiveness, by Product
15.4. Market Value Forecast, by Flow Regime, 2017–2031
15.4.1. Centrifugal Flow Pump (CFP)
15.4.2. Axial Flow Pump (AFP)
15.4.3. Mixed Flow Pump (MFP)
15.5. Market Attractiveness, by Flow Regime
15.6. Market Value Forecast, By Therapy, 2017–2031
15.6.1. Bridge-to-Candidacy (BTC)
15.6.2. Bridge-to-Transplant (BTT)
15.7. Market Attractiveness, By Therapy
15.8. Market Value Forecast, by Location, 2017–2031
15.8.1. Implantable Heart Pump Devices
15.8.2. Extracorporeal Heart Pump Devices
15.9. Market Attractiveness, by Location
15.10. Market Value Forecast, by End-user, 2017–2031
15.10.1. Hospitals
15.10.2. Ambulatory Surgical Centers
15.10.3. Specialty Clinics
15.10.4. Others
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2017–2031
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Product
15.13.2. By Flow Regime
15.13.3. By Therapy
15.13.4. By Location
15.13.5. By End-user
15.13.6. By Country/Sub-region
16. Middle East & Africa Heart Pumps Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product, 2017–2031
16.2.1. Intra-aortic Balloon Pumps
16.2.2. Ventricular Assist Devices
16.2.2.1. Left Ventricle Assist Devices (LVAD)
16.2.2.2. Right Ventricle Assist Devices (RVAD)
16.2.2.3. Biventricular Assist Devices (BVAD)
16.2.2.4. Others
16.2.3. Total Artificial Heart
16.3. Market Attractiveness, by Product
16.4. Market Value Forecast, by Flow Regime, 2017–2031
16.4.1. Centrifugal Flow Pump (CFP)
16.4.2. Axial Flow Pump (AFP)
16.4.3. Mixed Flow Pump (MFP)
16.5. Market Attractiveness, by Flow Regime
16.6. Market Value Forecast, By Therapy, 2017–2031
16.6.1. Bridge-to-Candidacy (BTC)
16.6.2. Bridge-to-Transplant (BTT)
16.7. Market Attractiveness, By Therapy
16.8. Market Value Forecast, by Location, 2017–2031
16.8.1. Implantable Heart Pump Devices
16.8.2. Extracorporeal Heart Pump Devices
16.9. Market Attractiveness, by Location
16.10. Market Value Forecast, by End-user, 2017–2031
16.10.1. Hospitals
16.10.2. Ambulatory Surgical Centers
16.10.3. Specialty Clinics
16.10.4. Others
16.11. Market Attractiveness, by End-user
16.12. Market Value Forecast, by Country/Sub-region, 2017–2031
16.12.1. GCC Countries
16.12.2. South Africa
16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
16.13.1. By Product
16.13.2. By Flow Regime
16.13.3. By Therapy
16.13.4. By Location
16.13.5. By End-user
16.13.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. SynCardia Systems, LLC
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Berlin Heart GmbH
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Jarvik Heart Inc.
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Calon Cardio-Technology Ltd.
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Teleflex Incorporated
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. Abbott Laboratories
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Medtronic plc
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
List of Tables
Table 01: Global Heart Pumps Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Heart Pumps Market Size (US$ Mn) Forecast, by Flow Regime, 2017-2031
Table 03: Global Heart Pumps Market Size (US$ Mn) Forecast, by Location, 2017-2031
Table 04: Global Heart Pumps Market Size (US$ Mn) Forecast, By Therapy, 2017-2031
Table 05: Global Heart Pumps Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 06: Global Heart Pumps Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 07: North America Heart Pumps Market Size (US$ Mn) Forecast, by Country, 2017-2031
Table 08: North America Heart Pumps Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 09: North America Heart Pumps Market Size (US$ Mn) Forecast, by Flow Regime, 2017-2031
Table 10: North America Heart Pumps Market Size (US$ Mn) Forecast, By Therapy, 2017-2031
Table 11: North America Heart Pumps Market Size (US$ Mn) Forecast, by Location, 2017-2031
Table 12: North America Heart Pumps Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Europe Heart Pumps Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Europe Heart Pumps Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Europe Heart Pumps Market Size (US$ Mn) Forecast, by Flow Regime, 2017-2031
Table 16: Europe Heart Pumps Market Size (US$ Mn) Forecast, By Therapy, 2017-2031
Table 17: Europe Heart Pumps Market Size (US$ Mn) Forecast, by Location, 2017-2031
Table 18: Europe Heart Pumps Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 19: Asia Pacific Heart Pumps Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 20: Asia Pacific Heart Pumps Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 21: Asia Pacific Heart Pumps Market Size (US$ Mn) Forecast, by Flow Regime, 2017-2031
Table 22: Asia Pacific Heart Pumps Market Size (US$ Mn) Forecast, By Therapy, 2017-2031
Table 23: Asia Pacific Heart Pumps Market Size (US$ Mn) Forecast, by Location, 2017-2031
Table 24: Asia Pacific Heart Pumps Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 25: Latin America Heart Pumps Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 26: Latin America Heart Pumps Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 27: Latin America Heart Pumps Market Size (US$ Mn) Forecast, by Flow Regime, 2017-2031
Table 28: Latin America Heart Pumps Market Size (US$ Mn) Forecast, By Therapy, 2017-2031
Table 29: Latin America Heart Pumps Market Size (US$ Mn) Forecast, by Location, 2017-2031
Table 30: Latin America Heart Pumps Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 31: Middle East & Africa Heart Pumps Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Middle East & Africa Heart Pumps Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 33: Middle East & Africa Heart Pumps Market Size (US$ Mn) Forecast, by Flow Regime, 2017-2031
Table 34: Middle East & Africa Heart Pumps Market Size (US$ Mn) Forecast, By Therapy, 2017-2031
Table 35: Middle East & Africa Heart Pumps Market Size (US$ Mn) Forecast, by Location, 2017-2031
Table 36: Middle East & Africa Heart Pumps Market Size (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Heart Pumps Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Heart Pumps Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Heart Pumps Market Value Share, by Product, 2022
Figure 04: Global Heart Pumps Market Revenue (US$ Mn), by Flow Regime, 2022
Figure 05: Global Heart Pumps Market Value Share, by Flow Regime, 2022
Figure 06: Global Heart Pumps Market Revenue (US$ Mn), By Therapy, 2022
Figure 07: Global Heart Pumps Market Value Share, By Therapy, 2022
Figure 08: Global Heart Pumps Market Revenue (US$ Mn), by Location, 2022
Figure 09: Global Heart Pumps Market Value Share, by Location, 2022
Figure 10: Global Heart Pumps Market Revenue (US$ Mn), by End-user, 2022
Figure 11: Global Heart Pumps Market Value Share, by End-user, 2022
Figure 12: Global Heart Pumps Market Value Share, by Region, 2022
Figure 13: Global Heart Pumps Market Value (US$ Mn) Forecast, 2017-2031
Figure 14: Global Heart Pumps Market Value Share Analysis, by Product, 2022 and 2031
Figure 15: Global Heart Pumps Market Attractiveness Analysis, by Product, 2023-2031
Figure 16: Global Heart Pumps Market Value Share Analysis, by Flow Regime, 2022 and 2031
Figure 17: Global Heart Pumps Market Attractiveness Analysis, by Flow Regime, 2023-2031
Figure 18: Global Heart Pumps Market Value Share Analysis, By Therapy, 2022 and 2031
Figure 19: Global Heart Pumps Market Attractiveness Analysis, By Therapy, 2023-2031
Figure 20: Global Heart Pumps Market Revenue (US$ Mn), by Location, 2022
Figure 21: Global Heart Pumps Market Value Share, by Location, 2022
Figure 22: Global Heart Pumps Market Revenue (US$ Mn), by End-user, 2022
Figure 23: Global Heart Pumps Market Value Share, by End-user, 2022
Figure 24: Global Heart Pumps Market Value Share Analysis, by Region, 2022 and 2031
Figure 25: Global Heart Pumps Market Attractiveness Analysis, by Region, 2023-2031
Figure 26: North America Heart Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 27: North America Heart Pumps Market Attractiveness Analysis, by Country, 2023-2031
Figure 28: North America Heart Pumps Market Value Share Analysis, by Country, 2022 and 2031
Figure 29: North America Heart Pumps Market Value Share Analysis, by Product, 2022 and 2031
Figure 30: North America Heart Pumps Market Value Share Analysis, by Flow Regime, 2022 and 2031
Figure 31: North America Heart Pumps Market Value Share Analysis, By Therapy, 2022 and 2031
Figure 32: North America Heart Pumps Market Value Share Analysis, by Location, 2022 and 2031
Figure 33: North America Heart Pumps Market Value Share Analysis, by End-user, 2022 and 2031
Figure 34: North America Heart Pumps Market Attractiveness Analysis, by Product, 2023-2031
Figure 35: North America Heart Pumps Market Attractiveness Analysis, by Flow Regime, 2023-2031
Figure 36: North America Heart Pumps Market Attractiveness Analysis, By Therapy, 2023-2031
Figure 37: North America Heart Pumps Market Attractiveness Analysis, by Location, 2023-2031
Figure 38: North America Heart Pumps Market Attractiveness Analysis, by End-user, 2023-2031
Figure 39: Europe Heart Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 40: Europe Heart Pumps Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 41: Europe Heart Pumps Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 42: Europe Heart Pumps Market Value Share Analysis, by Product, 2022 and 2031
Figure 43: Europe Heart Pumps Market Value Share Analysis, by Flow Regime, 2022 and 2031
Figure 44: Europe Heart Pumps Market Value Share Analysis, By Therapy, 2022 and 2031
Figure 45: Europe Heart Pumps Market Value Share Analysis, by Location, 2022 and 2031
Figure 46: Europe Heart Pumps Market Value Share Analysis, by End-user, 2022 and 2031
Figure 47: Europe Heart Pumps Market Attractiveness Analysis, by Product, 2023-2031
Figure 48: Europe Heart Pumps Market Attractiveness Analysis, by Flow Regime, 2023-2031
Figure 49: Europe Heart Pumps Market Attractiveness Analysis, By Therapy, 2023-2031
Figure 50: Europe Heart Pumps Market Attractiveness Analysis, by Location, 2023-2031
Figure 51: Europe Heart Pumps Market Attractiveness Analysis, by End-user, 2023-2031
Figure 52: Asia Pacific Heart Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 53: Asia Pacific Heart Pumps Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 54: Asia Pacific Heart Pumps Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 55: Asia Pacific Heart Pumps Market Value Share Analysis, by Product, 2022 and 2031
Figure 56: Asia Pacific Heart Pumps Market Value Share Analysis, by Flow Regime, 2022 and 2031
Figure 57: Asia Pacific Heart Pumps Market Value Share Analysis, By Therapy, 2022 and 2031
Figure 58: Asia Pacific Heart Pumps Market Value Share Analysis, by Location, 2022 and 2031
Figure 59: Asia Pacific Heart Pumps Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Asia Pacific Heart Pumps Market Attractiveness Analysis, by Product, 2023-2031
Figure 61: Asia Pacific Heart Pumps Market Attractiveness Analysis, by Flow Regime, 2023-2031
Figure 62: Asia Pacific Heart Pumps Market Attractiveness Analysis, By Therapy, 2023-2031
Figure 63: Asia Pacific Heart Pumps Market Attractiveness Analysis, by Location, 2023-2031
Figure 64: Asia Pacific Heart Pumps Market Attractiveness Analysis, by End-user, 2023-2031
Figure 65: Latin America Heart Pumps Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 66: Latin America Heart Pumps Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 67: Latin America Heart Pumps Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 68: Latin America Heart Pumps Market Value Share Analysis, by Product, 2022 and 2031
Figure 69: Latin America Heart Pumps Market Value Share Analysis, by Flow Regime, 2022 and 2031
Figure 70: Latin America Heart Pumps Market Value Share Analysis, By Therapy, 2022 and 2031
Figure 71: Latin America Heart Pumps Market Value Share Analysis, by Location, 2022 and 2031
Figure 72: Latin America Heart Pumps Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Latin America Heart Pumps Market Attractiveness Analysis, by Product, 2023-2031
Figure 74: Latin America Heart Pumps Market Attractiveness Analysis, by Flow Regime, 2023-2031
Figure 75: Latin America Heart Pumps Market Attractiveness Analysis, By Therapy, 2023-2031
Figure 76: Latin America Heart Pumps Market Attractiveness Analysis, by Location, 2023-2031
Figure 77: Latin America Heart Pumps Market Attractiveness Analysis, by End-user, 2023-2031
Figure 78: Middle East & Africa Heart Pumps Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 79: Middle East & Africa Heart Pumps Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 80: Middle East & Africa Heart Pumps Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 81: Middle East & Africa Heart Pumps Market Value Share Analysis, by Product, 2022 and 2031
Figure 82: Middle East & Africa Heart Pumps Market Value Share Analysis, by Flow Regime, 2022 and 2031
Figure 83: Middle East & Africa Heart Pumps Market Value Share Analysis, By Therapy, 2022 and 2031
Figure 84: Middle East & Africa Heart Pumps Market Value Share Analysis, by Location, 2022 and 2031
Figure 85: Middle East & Africa Heart Pumps Market Value Share Analysis, by End-user, 2022 and 2031
Figure 86: Middle East & Africa Heart Pumps Market Attractiveness Analysis, by Product, 2023-2031
Figure 87: Middle East & Africa Heart Pumps Market Attractiveness Analysis, by Flow Regime, 2023-2031
Figure 88: Middle East & Africa Heart Pumps Market Attractiveness Analysis, By Therapy, 2023-2031
Figure 89: Middle East & Africa Heart Pumps Market Attractiveness Analysis, by Location, 2023-2031
Figure 90: Middle East & Africa Heart Pumps Market Attractiveness Analysis, by End-user, 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Heart Pumps Market
